Navigation Links
Sorbent Therapeutics Initiates Phase 2b Clinical Trial of CLP-1001 for Treatment of Signs and Symptoms of Fluid Overload in Patients with Heart Failure
Date:4/11/2013

SUNNYVALE, Calif., April 11, 2013 /PRNewswire/ -- Sorbent Therapeutics, Inc., a biopharmaceutical company developing therapies for cardiovascular and renal diseases, today announced that patient dosing has commenced in its Phase 2b clinical trial of CLP-1001.  This trial, known as STEPWISE (a randomized, double-blind, multi-center STudy comparing cross-linkEd Polyelectrolyte (CLP) WIth placebo in HF SubjEcts), is designed to evaluate the safety and efficacy of CLP-1001 in addressing signs and symptoms of fluid overload in patients with congestive heart failure (HF).  CLP-1001 is a novel, non-absorbed oral polymer that acts by binding to and removing excess sodium and fluid in the GI tract independently of the kidneys.

"The objective of the STEPWISE trial is to further understand the magnitude of the effect of CLP-1001 on key measures and clinical endpoints of heart failure-induced congestion compared to current standard of care," said Howard C. Dittrich , M.D., F.A.C.C., Chief Medical Officer of Sorbent.  "Fluid overload in heart failure patients contributes importantly to hospitalizations -- including re-hospitalizations -- slows in-patient recovery, and results in poor quality of life and physical limitations.  Based on the positive clinical benefits observed in our Phase 2a clinical trial, we look forward to advancing CLP-1001 through late-stage registration studies."   

STEPWISE is a double-blind, randomized, placebo-controlled, multicenter, study designed to evaluate CLP-1001 in patients with heart failure.  Approximately 250 patients on stable, optimized, guideline heart failure therapy that have signs and symptoms of current fluid overload after a recent HF-related hospitalization will be randomized to receive 15 grams of CLP-1001 or placebo.  The primary objective of this trial is to assess the change from baseline to eight weeks across sever
'/>"/>

SOURCE Sorbent Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sorbent Therapeutics CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study
2. Sorbent Therapeutics Presents CLP1001 Phase 2a Study Results at the 16th Annual Meeting of the Heart Failure Society of America
3. Sorbent Therapeutics Appoints Jason Levin Chief Business Officer
4. CytoSorbents Receives Approximately $400,000 in Non-Dilutive Capital from the Sale of Net Operating Loss Carryovers
5. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
6. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
8. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
9. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
10. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
11. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Sept. 1, 2015 Sargas Pharmaceutical Adherence ... and Drug Adherence m Health applications along with ... process of non face-to-face monitoring of twenty minutes ... release of our apps, doctors are now well ... with our ONCHIT certified Physician, Pharmacy and Patient ...
(Date:9/1/2015)... Within just two years after reaching a ... reached 3,000 employees worldwide. This increase is reflecting ... drug delivery market and SHL,s effective commitment, productivity ... the design and manufacturing of auto injectors and ... capabilities, a lean supply chain, strong partnerships, and ...
(Date:9/1/2015)... 2015 Egalet Corporation (Nasdaq: EGLT ... focused on discovering, developing, and commercializing innovative pain ... scientific data on SPRIX ® (ketorolac tromethamine) ... product candidate, and Egalet-002, an abuse-deterrent, extended-release, oral ... 2015 to be held September 8 to 12 ...
Breaking Medicine Technology:SPAC International's Drug Adherence and Chronic Care Management App Now available at Apple App and Google Play stores 2SHL Group Reaches Major Milestone of 3000 Employees 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 3Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 4Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 5Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 6
... Inc., a privately-held therapeutic device company, today announced ... with Bezwada Biomedical to develop and commercialize Bezwada,s ... Biomedical is an innovation-driven company with proprietary technology ... polyamides derived from hydrolyzable isocyanates. This technology can ...
... Aug. 31, 2011 Assured Pharmacy, Inc. (Pink Sheets: ... that provide advanced prescription services to a diverse array ... it sold in a private placement to an accredited ... an aggregate principal amount of $400,000 due December 1, ...
Cached Medicine Technology:ORTHOCON Announces Signing of Exclusive, Worldwide License Agreement With Bezwada Biomedical 2Assured Pharmacy, Inc. Receives Gross Proceeds of $400,000 from Sale of Convertible Debentures and Warrants 2Assured Pharmacy, Inc. Receives Gross Proceeds of $400,000 from Sale of Convertible Debentures and Warrants 3
(Date:9/1/2015)... ... September 01, 2015 , ... WorkCare, Inc., a national ... medical management team as an Associate Medical Director. , WorkCare specializes in ... the U.S. and abroad. , Dr. Nelson has a diverse background. He ...
(Date:9/1/2015)... ... 01, 2015 , ... SC&H Group, a leading audit, tax, and consulting firm, ... of the Best” firm in the U.S., as well as being ranked a Top ... in the U.S., selected exclusively on performance in specific areas of financial and operational ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... Mercy Health ... has devoted the 10th of its monthly Mercy Health: Helping You Be Well videos ... one in seven men. , In a concise video on Mercy Health’s YouTube ...
(Date:9/1/2015)... FL (PRWEB) , ... September 01, 2015 , ... ... discount cards, launched its consumer-friendly, informational video this week to coincide with back-to-school ... http://www.USAMedicalCard.com/video . , According to the CDC, elementary school children are sick ...
(Date:9/1/2015)... OHIO (PRWEB) , ... September 01, 2015 , ... Dr. ... today at JourneyLite of Cincinnati. In the last month the FDA has approved ... ReShape Duo ™. These procedures represent the first incisionless, reversible, weight loss procedures ...
Breaking Medicine News(10 mins):Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 3Health News:SC&H Group Receives Multiple Honors from INSIDE Public Accounting 2Health News:New Mercy Health Video Explains Most-Common Cancer Found in Men 2Health News:USA Medical Card Launches New FAQ Video During Back-to-School 2Health News:Dr. Trace Curry Performs First ORBERA™ Intra-gastric Balloon in Ohio at JourneyLite, a New Incisionless Option For The Treatment of Obesity 2
... the skin unleashes a complex cascade of chemistry to stem ... of Medicine in St. Louis have used evolutionary clues to ... new light on common bleeding disorders. The long tube-shaped ... von Willebrand Factor (VWF). Made in cells that form the ...
... to improve global health, alleviate hunger, raise living standards ... an important role to play. Jagdev ... and Vaccinology at Arizona State University,s Biodesign Institute has ... of chicken for villagers in rural Uganda. He reports ...
... WEDNESDAY, July 20 (HealthDay News) -- The number of surgical ... new study finds. In reviewing adverse events and close ... report in the July 15 issue of the Archives ... a greater emphasis on safety, as well as improved training ...
... in the Breast Health Center at Women & Infants ... to earn a 2011 Breast Cancer Symposium Merit Award ... of Clinical Oncology (ASCO). The award, which recognizes ... to Shannon MacLaughlan, MD, who is also affiliated with ...
... that is affected during the onset of schizophrenia and successfully ... drug currently in advanced clinical trials., The research, published ... group led by Professor Peter Giese at King,s College London, ... Schizophrenia is one of the most common serious mental health ...
... of thousands of people, injuring a muscle through an accident ... in a strange and serious complication. Their muscles start growing ... abnormal bone growth, so there was no treatment. But now, ... Perelman School of Medicine at the University of Pennsylvania shows ...
Cached Medicine News:Health News:Evolution provides clue to blood clotting 2Health News:Evolution provides clue to blood clotting 3Health News:A new breed: Highly productive chickens help raise Ugandans from poverty 2Health News:A new breed: Highly productive chickens help raise Ugandans from poverty 3Health News:Fewer Surgical Errors Reported at VA Medical Facilities 2Health News:Cancer drugs may help treatment of schizophrenia 2Health News:When injured muscles mistakenly grow bones 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: